Table 2.
Number of falls/fractures | Number of participants | Model 1 OR (95 % CI) |
Model 2 OR (95 % CI) |
Model 3 OR (95 % CI) |
|
---|---|---|---|---|---|
Falls | |||||
NGM | 204 | 1246 | Ref | Ref | Ref |
IGM | 72 | 359 | 1.28 (0.95–1.73) | 1.37 (1.01–1.87) | 1.28 (0.93–1.77) |
- IFG | 16 | 93 | 1.06 (0.61–1.86) | 1.25 (0.71–2.20) | 1.16 (0.65–2.07) |
- IGT | 56 | 266 | 1.36 (0.98–1.90) | 1.42 (1.01–1.99) | 1.32 (0.93–1.89) |
T2DM | 66 | 400 | 1.01 (0.75–1.37) | 1.17 (0.85–1.62) | 0.95 (0.64–1.40) |
Fractures | |||||
NGM | 119 | 1162 | Ref | Ref | Ref |
IGM | 40 | 326 | 1.23 (0.84–1.80) | 1.20 (0.80–1.78) | 1.28 (0.84–1.95) |
- IFG | 9 | 85 | 1.04 (0.51–2.13) | 1.24 (0.59–2.58) | 1.30 (0.62–2.76) |
- IGT | 31 | 241 | 1.29 (0.85–1.97) | 1.19 (0.76–1.85) | 1.28 (0.81–2.02) |
T2DM | 19 | 359 | 0.49 (0.30–0.81) | 0.55 (0.32–0.92) | 0.70 (0.38–1.27) |
Model 1: unadjusted, model 2: adjusted for age, sex, and level of education, model 3: model 2 + BMI, MVPA, a history of CVD, smoking status, alcohol consumption, the use of blood pressure lowering drugs, the use of lipid-modifying drugs, the use of sleep medication, depression, and cognitive function. NGM is the reference category
CI confidence interval, IGM impaired glucose metabolism, NGM normal glucose metabolism, OR odds ratio, T2DM type 2 diabetes mellitus
Statistically significant results are presented in italic